Thanks for your submission. We'll get back to you soon!

Our Team

PathAI is the world’s leading provider of AI-powered technology for the pathology laboratory.

Andrew Beck

Andrew H. Beck, MD PhD

Co-Founder & CEO

Andy earned his MD from Brown Medical School and completed residency and fellowship training in Anatomic Pathology and Molecular Genetic Pathology from Stanford University. He completed a PhD in Biomedical Informatics from Stanford University, where he developed one of the first machine-learning based systems for cancer pathology. He's been certified by the American Board of Pathology in Anatomic Pathology and Molecular Genetic Pathology. Prior to co-founding PathAI, he was on the faculty of Harvard Medical School in the Department of Pathology at Beth Israel Deaconess Medical Center. He has published over 110 papers in the fields of cancer biology, cancer pathology, and biomedical informatics.

Aditya Khosla

Aditya Khosla, PhD

Co-Founder & CTO

Aditya recently completed his PhD in machine learning and computer vision at MIT. He completed his MS at Stanford in 2011 and BS at Caltech in 2009. In his research he developed new methods for an array of applications in computer vision, including eye-tracking, prediction of image memorability, and visualization of deep networks. He is the recipient of a Facebook Fellowship and his work has been widely covered by various media outlets including BBC, The New York Times and The Washington Post. He has published over 30 papers in the fields of deep learning, computer vision and neuroscience.

Esther Abels

VP Regulatory Affairs, Clinical Affairs & Strategic Business Development

Tiffany Freitas

Chief Business Officer

Mike Montalto

Chief Scientific Officer

Don O'Neill

VP of Engineering

Jess Riley

VP Business Development & Companion Diagnostics

Dayong Wang

VP Machine Learning

Jackson Wilkinson

SVP Information & Security

Board Members

Rob Perez

Rob Perez

Operating Partner, General Atlantic

Stan Lapidus

Stan Lapidus

CEO, Lapidx Research

Jeff Leiden

Jeff Leiden

CEO, Vertex Pharmaceuticals

Investors

General Atlantic Logo General Catalyst Logo Refactor Capital Logo 8VC Logo Pillar Logo Danhua Capital Logo KDT Logo